Shinva Medical Instrument Co., Ltd. (600587.SS)
CNY 17.62
(0.17%)
CNY 17.62
(0.17%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 10.01 Billion | 9.28 Billion | 9.48 Billion | 9.15 Billion | 8.76 Billion | 10.28 Billion |
| Cost of Revenue | 7.27 Billion | 6.82 Billion | 7.18 Billion | 7.02 Billion | 6.9 Billion | 8.22 Billion |
| Gross Profit | 2.74 Billion | 2.45 Billion | 2.29 Billion | 2.13 Billion | 1.86 Billion | 2.05 Billion |
| Operating Expenses | 1.95 Billion | 1.76 Billion | 1.62 Billion | 1.51 Billion | 1.52 Billion | 1.42 Billion |
| Selling, General and Administrative Expenses | 1.51 Billion | 1.03 Billion | 1.02 Billion | 1.02 Billion | 1.08 Billion | 1.02 Billion |
| Research and Development Expenses | 443.36 Million | 401.27 Million | 295.97 Million | 197.53 Million | 164.08 Million | 124.87 Million |
| Other Expenses | -9.65 Million | 323.01 Million | 310.08 Million | 287.47 Million | 279.27 Million | -5.89 Million |
| Cost and Expenses | 9.25 Billion | 8.58 Billion | 8.81 Billion | 8.53 Billion | 8.42 Billion | 9.65 Billion |
| Operating Income | 756.95 Million | 585.83 Million | 720.18 Million | 650.93 Million | 1.12 Billion | 249.02 Million |
| Interest Expense | 47.07 Million | 56.93 Million | 76.26 Million | 121.44 Million | 171.75 Million | 189.52 Million |
| Income Tax Expense | 62.07 Million | 46.88 Million | 162 Million | 105.89 Million | 260.54 Million | 120.92 Million |
| Earnings before Tax | 738.57 Million | 576.09 Million | 718.02 Million | 345.3 Million | 1.12 Billion | 243.13 Million |
| Net Income | 653.99 Million | 500.07 Million | 556.49 Million | 234.13 Million | 861.31 Million | 22.78 Million |
| Earnings Per Share Basic | 1.10 | 1.23 | 1.37 | 0.58 | 2.12 | 0.06 |
| Earnings Per Share Diluted | 1.10 | 1.23 | 1.37 | 0.58 | 2.12 | 0.06 |
| Weighted Average Shares Outstanding | 594.54 Million | 406.42 Million | 406.42 Million | 406.42 Million | 406.42 Million | 379.73 Million |
| Weighted Average Shares Outstanding (Diluted) | 594.54 Million | 406.42 Million | 406.42 Million | 406.42 Million | 406.42 Million | 379.73 Million |
| Gross Margin | 0.27 | 0.26 | 0.24 | 0.23 | 0.21 | 0.20 |
| EBIT Margin | 0.10 | 0.10 | 0.10 | 0.09 | 0.18 | 0.08 |
| Profit Margin | 0.07 | 0.05 | 0.06 | 0.03 | 0.10 | 0.00 |
| EBITDA | 967.71 Million | 830.36 Million | 1.02 Billion | 661.77 Million | 1.47 Billion | 618.67 Million |
| Earnings Before Tax Margin | 0.08 | 0.06 | 0.08 | 0.07 | 0.13 | 0.02 |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Revenue | 2.23 Billion | 2.65 Billion | 2.51 Billion | 10.01 Billion | 2.69 Billion | 2.24 Billion |
| Cost of Revenue | 1.66 Billion | 1.89 Billion | 1.9 Billion | 7.27 Billion | 1.98 Billion | 1.6 Billion |
| Gross Profit | 570.92 Million | 758.29 Million | 609.79 Million | 2.74 Billion | 714.99 Million | 635.31 Million |
| Operating Expenses | 428.24 Million | 428.44 Million | 391.99 Million | 1.93 Billion | 573.7 Million | 477.42 Million |
| Selling, General and Administrative Expenses | 740.76 Million | 170.36 Million | 310.17 Million | - | 62.54 Million | 525.6 Million |
| Research and Development Expenses | 111.87 Million | 101.96 Million | 83.3 Million | - | 152.05 Million | 112.73 Million |
| Other Expenses | -424.39 Million | 298.11 Thousand | 1.48 Million | -18.37 Million | -20.5 Million | 1.49 Million |
| Cost and Expenses | 2.09 Billion | 2.32 Billion | 2.29 Billion | 9.2 Billion | 2.55 Billion | 2.08 Billion |
| Operating Income | 160.92 Million | 327.17 Million | 217.79 Million | 756.95 Million | 67.59 Million | 144.44 Million |
| Interest Expense | 11.11 Million | 9.11 Million | 13.62 Million | 47.07 Million | 7.22 Million | 14.59 Million |
| Income Tax Expense | 20.71 Million | 44.43 Million | 24.98 Million | 62.07 Million | -23.63 Million | 17.74 Million |
| Earnings before Tax | 156.6 Million | 327.46 Million | 226.85 Million | 738.57 Million | 47.08 Million | 145.94 Million |
| Net Income | 132.73 Million | 273.22 Million | 211.03 Million | 653.99 Million | 75.33 Million | 119.96 Million |
| Earnings Per Share Basic | 0.22 | 0.53 | 0.46 | - | 0.16 | 0.26 |
| Earnings Per Share Diluted | 0.22 | 0.53 | 0.46 | - | 0.16 | 0.26 |
| Weighted Average Shares Outstanding | 599.72 Million | 513.05 Million | 461.32 Million | 457.34 Million | 461.13 Million | 461.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 599.72 Million | 513.05 Million | 461.32 Million | 457.34 Million | 461.13 Million | 461.13 Million |
| Gross Margin | 0.26 | 0.29 | 0.24 | 0.27 | 0.27 | 0.28 |
| EBIT Margin | 0.07 | 0.13 | 0.11 | - | 0.06 | 0.08 |
| Profit Margin | 0.06 | 0.10 | 0.08 | 0.07 | 0.03 | 0.05 |
| EBITDA | 167.72 Million | 356.68 Million | 269.81 Million | - | 156.26 Million | 190.65 Million |
| Earnings Before Tax Margin | 0.07 | 0.12 | 0.09 | 0.08 | 0.03 | 0.06 |
ATSG
SYG
SSKN
300314
AGILC
CLCO